首页> 外文期刊>BMC Cancer >Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis
【24h】

Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis

机译:表观扩散系数不能预测侵袭性乳腺癌中的分子亚型和淋巴结转移:多中心分析

获取原文
           

摘要

BACKGROUND:Radiological imaging plays a central role in the diagnosis of breast cancer (BC). Some studies suggest MRI techniques like diffusion weighted imaging (DWI) may provide further prognostic value by discriminating between tumors with different biologic characteristics including receptor status and molecular subtype. However, there is much contradictory reported data regarding such associations in the literature. The purpose of the present study was to provide evident data regarding relationships between quantitative apparent diffusion coefficient (ADC) values on DWI and pathologic prognostic factors in BC.METHODS:Data from 5 centers (661 female patients, mean age, 51.4?±?10.5?years) were acquired. Invasive ductal carcinoma (IDC) was diagnosed in 625 patients (94.6%) and invasive lobular carcinoma in 36 cases (5.4%). Luminal A carcinomas were diagnosed in 177 patients (28.0%), luminal B carcinomas in 279 patients (44.1%), HER 2+ carcinomas in 66 cases (10.4%), and triple negative carcinomas in 111 patients (17.5%). The identified lesions were staged as T1 in 51.3%, T2 in 43.0%, T3 in 4.2%, and as T4 in 1.5% of the cases. N0 was found in 61.3%, N1 in 33.1%, N2 in 2.9%, and N3 in 2.7%. ADC values between different groups were compared using the Mann-Whitney U test and by the Kruskal-Wallis H test. The association between ADC and Ki 67 values was calculated by Spearman's rank correlation coefficient.RESULTS:ADC values of different tumor subtypes overlapped significantly. Luminal B carcinomas had statistically significant lower ADC values compared with luminal A (p?=?0.003) and HER 2+ (p?=?0.007) lesions. No significant differences of ADC values were observed between luminal A, HER 2+ and triple negative tumors. There were no statistically significant differences of ADC values between different T or N stages of the tumors. Weak statistically significant correlation between ADC and Ki 67 was observed in luminal B carcinoma (r?=?-?0.130, p?=?0.03). In luminal A, HER 2+ and triple negative tumors there were no significant correlations between ADC and Ki 67.CONCLUSION:ADC was not able to discriminate molecular subtypes of BC, and cannot be used as a surrogate marker for disease stage or proliferation activity.
机译:背景:放射性影像在乳腺癌(BC)的诊断中起着重要作用。一些研究表明,像扩散加权成像(DWI)这样的MRI技术可以通过在具有不同生物特征的肿瘤之间鉴定包括受体状态和分子亚型的肿瘤来提供进一步的预后值。但是,有很多矛盾的报告了关于文献中的这种协会的数据。本研究的目的是提供关于在BC.Methods的定量表观扩散系数(ADC)值与病理预后因子的定量表观扩散系数(ADC)值之间的关系:来自5个中心的数据(661例女性患者,平均年龄,51.4?±10.5年份)被收购。侵入性导管癌(IDC)被诊断为625名患者(94.6%)和侵袭性小叶癌36例(5.4%)。 Luminal在177名患者(28.0%)中诊断出癌癌,在279例患者(44.1%),她的2次癌癌中,在66例(10.4%)和111名患者中的三阴阴阳瘤(17.5%)中,患者。将鉴定的病变分期为T1,在43.0%,T3中以4.2%的4.2%,在1.5%的情况下为4.2%。 N0在61.3%,N1中发现33.1%,N 2为2.9%,N3为2.7%。使用Mann-Whitney U测试和Kruskal-Wallis H测试进行比较不同组之间的ADC值。 ADC和ki 67值之间的关联由Spearman的秩相关系数计算。结果:不同肿瘤亚型的ADC值显着重叠。与腔A(p≤= 0.003)和她的2+(p?= 0.007)病变相比,Luminal B癌患者具有统计学显着的较低的ADC值。在腔A,2+和三重阴性肿瘤之间没有观察到ADC值的显着差异。在肿瘤的不同T或N阶段之间没有统计学上的adc值差异。在腔B癌(Rα= - →0.130,p≤0.03)中观察到ADC和KI 67之间的弱统计学相关性。在腔A中,她的2+和三重阴性肿瘤在Adc和Ki 67之间没有显着的相关性。结论:ADC不能区分BC的分子亚型,并且不能用作疾病阶段或增殖活性的替代标记物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号